Comparative Efficacy of Ticagrelor Versus Aspirin on Blood Viscosity in Peripheral Artery Disease (PAD) Patients With Type 2 Diabetes (T2D)
Phase of Trial: Phase III
Latest Information Update: 29 Sep 2016
At a glance
- Drugs Aspirin (Primary) ; Ticagrelor (Primary)
- Indications Peripheral arterial occlusive disorders; Type 2 diabetes mellitus
- Focus Therapeutic Use
- 19 Sep 2016 Planned End Date changed from 1 Nov 2016 to 1 Dec 2017.
- 19 Sep 2016 Planned primary completion date changed from 1 Nov 2016 to 1 Dec 2017.
- 06 Jan 2015 New trial record